PCaVision Overview
- Year Founded
-
2008
- Status
-
Private
- Employees
-
31
- Latest Deal Type
-
Crowdfunding
- Latest Deal Amount
-
$2.1M
- Investors
-
9
PCaVision General Information
Description
Developer of an ultrasound imaging medical device designed to detect, localize, and characterize prostate cancer tumors with improved efficiency. The company's device replaces the biopsy-based diagnosis by eliminating infection risk, reducing cost, and increasing patient comfort and outcomes, enabling clinicians to treat and predict prostate cancer without any hassle.
Contact Information
Website
www.pcavision.comCorporate Office
- JADS Venture Campus
- Sint Janssingel 88
- 5211 DA S-Hertogenbosch
- Netherlands
Corporate Office
- JADS Venture Campus
- Sint Janssingel 88
- 5211 DA S-Hertogenbosch
- Netherlands
PCaVision Timeline
PCaVision Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 14. Equity Crowdfunding | 01-Nov-2025 | $2.1M | Completed | Generating Revenue | ||
| 13. Later Stage VC (Series A) | 16-Sep-2025 | Completed | Generating Revenue | |||
| 12. Later Stage VC | 01-Jan-2021 | Completed | Generating Revenue | |||
| 11. Later Stage VC | Completed | Generating Revenue | ||||
| 10. Grant | 01-Dec-2020 | Completed | Generating Revenue | |||
| 9. Seed Round | 17-Feb-2020 | Completed | Generating Revenue | |||
| 8. Grant | 01-Dec-2019 | Completed | Startup | |||
| 7. Grant | 01-Dec-2018 | Completed | Startup | |||
| 6. Seed Round | 10-Jul-2018 | Completed | Startup | |||
| 5. Grant | 01-Dec-2017 | $1.19M | Completed | Startup |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
PCaVision Patents
PCaVision Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-3347874-A1 | Imaging of dispersion and velocity of contrast agents | Active | 09-Sep-2015 | ||
| EP-3347874-B1 | Imaging of dispersion and velocity of contrast agents | Active | 09-Sep-2015 | ||
| US-10789711-B2 | Imaging of dispersion and velocity of contrast agents | Active | 09-Sep-2015 | ||
| US-20200234446-A1 | Imaging of dispersion and velocity of contrast agents | Active | 09-Sep-2015 | ||
| US-9141766-B2 | Perfusion scanning detects angiogenesis from similarity in evolution of local concentrations of contrast agent | Active | 27-Sep-2011 |
PCaVision Signals
PCaVision Investors (9)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Living Hope VC | Venture Capital | Minority | ||
| CbusineZ | Corporate Venture Capital | Minority | ||
| National Institutes of Health | Government | |||
| Hanarth Fonds | Other | |||
| NLC Health Ventures | Venture Capital | Minority |
PCaVision FAQs
-
When was PCaVision founded?
PCaVision was founded in 2008.
-
Where is PCaVision headquartered?
PCaVision is headquartered in S-Hertogenbosch, Netherlands.
-
What is the size of PCaVision?
PCaVision has 31 total employees.
-
What industry is PCaVision in?
PCaVision’s primary industry is Diagnostic Equipment.
-
Is PCaVision a private or public company?
PCaVision is a Private company.
-
What is PCaVision’s current revenue?
The current revenue for PCaVision is .
-
How much funding has PCaVision raised over time?
PCaVision has raised $5.12M.
-
Who are PCaVision’s investors?
Living Hope VC, CbusineZ, National Institutes of Health, Hanarth Fonds, and NLC Health Ventures are 5 of 9 investors who have invested in PCaVision.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process